Here is a selection of articles. For a full list of my articles for InPharm please click here.
Health outcomes - does anything else matter?
So the mould of British politics has been broken, and we now have a government with probably a broader range of views than we have ever had before.
27th October 2010
Not so New Technologies
InPharm R&D Review
Not that much has changed in the world of health research IT systems, despite technological leaps, as it’s user vision that counts.
28th July 2010
Power to the Project Manager
Why is project management undervalued in pharma R & D?
InPharm R&D Review
14th July 2010
Building Value: Is the pipeline all that matters?
The whole company adds value, not just its products.
InPharm R&D Review
1st December 2009
British health care regulation moves away from science. Biologist 54 (1) 3-5. Not available online to non-members. Email me for a reprint.
Learning from Northwick Park
The new generation of biotech drugs could require pharma to redefine its clinical trials procedures. Pharmafocus Thursday, March 01, 2007
Time to get back to our scientific basics
Pharma has never been good at convincing the public of the benefits of clinical trials, but after the Northwick Park incident, it now needs to do this more than ever. Pharmafocus Wednesday, August 23, 2006
Gene therapy: the tailor-made treatment
Although their utility is hotly debated, genetic studies are increasingly used in pivotal clinical trials and gene therapy is becoming the clever tool of tomorrow. Pharmafocus Friday, July 21, 2006
What is truth? Thoughts of a born-again sceptic. Biologist 51 (3) 1-3. Sorry, not available online but you can email me for a reprint.
| 
